SynthesisFrontiers in pharmacology2025

A systematic review and meta-analysis of efruxifermin's efficacy in improving liver fibrosis in patients with NASH/MASH.

Shuzhai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.